Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Strategic Implications International is a specialized consultancy providing strategic advisory and analytical services to the biopharmaceutical, biotechnology, and life sciences sectors. The firm is known for its extensive research into the history of drug development, regulatory trends, and the commercial lifecycle of therapeutic products. Founded by industry expert Dr. Michael Kinch, the company assists clients in navigating complex R&D landscapes through data-driven competitive intelligence and market analysis. Their expertise is often utilized by investors and pharmaceutical executives to evaluate the long-term viability of various therapeutic modalities and pipelines. The organization leverages proprietary datasets to track the evolution of the industry's molecular anatomy, offering unique insights into R&D productivity. By bridging the gap between academic research and commercial strategy, the firm provides a comprehensive view of the challenges and opportunities within modern medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Strategic Implications International.